Stock AYA ARTRYA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Artrya Limited

Equities

AYA

AU0000182412

Market Closed - Australian S.E.
Other stock markets
 11:41:03 07/06/2024 am IST 		5-day change 1st Jan Change
0.255 AUD +2.00% Intraday chart for Artrya Limited -5.56% +6.25%
03:21am Artrya Submits Second Q-Submission to Finalize FDA Application MT
02/04 Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8% MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Artrya Submits Second Q-Submission to Finalize FDA Application
MT
Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8%
MT
Artrya Gears Up for US Launch After Tanner Health System Partnership
MT
Artrya Limited Reports Earnings Results for the Six Months Ended December 31, 2023
CI
Weekly Top Ten News Stories - 23 February 2024
AQ
12,000,000 Options of Artrya Limited are subject to a Lock-Up Agreement Ending on 26-NOV-2023.
CI
15,610,470 Ordinary Shares of Artrya Limited are subject to a Lock-Up Agreement Ending on 26-NOV-2023.
CI
Artrya Enters US Market Via Strategic Commercial Partnership
MT
Artrya Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Artrya Completes Q-Submission Meeting with US FDA for Salix Product
MT
Worries of Rate Hike Drag on Financial Markets Send Australian Shares into Losses
MT
Artrya Completes Key Step for US Regulatory Approval of Coronary Artery Software
MT
John Barrington AM to Step Down from the Board and Resign as Managing Director of Artrya Limited
CI
Artrya Limited Announces CEO Changes
CI
Artrya Limited Announces Board Changes
CI
Artrya Limited Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Artrya Obtains UK Regulatory Approval for Salix Coronary Anatomy Product
MT
Artrya Limited Gains UK Regulatory Approval for its Salix Coronary Anatomy Product
CI
Artrya Secures EU Approval for Coronary Analysis Product
MT
Artrya Limited Receives Regulatory Approval for Its Salix Coronary Anatomy Product in Europe
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AYA Stock
  4. News Artrya Limited